Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1989 2
1990 9
1991 1
1992 3
1993 6
1994 3
1995 6
1996 4
1997 6
1998 4
1999 3
2001 2
2004 3
2007 1
2009 1
2010 1
2011 3
2012 3
2014 1
2015 1
2016 1
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 1600494

64 results

Results by year

Filters applied: . Clear all
Page 1
Controversies in the treatment of metastatic prostate cancer.
McLeod DG, Crawford ED, Blumenstein BA, Eisenberger MA, Dorr FA. McLeod DG, et al. Cancer. 1992 Jul 1;70(1 Suppl):324-8. doi: 10.1002/1097-0142(19920701)70:1+<324::aid-cncr2820701321>3.0.co;2-g. Cancer. 1992. PMID: 1600494 Clinical Trial.
The use of flutamide in hormone-refractory metastatic prostate cancer.
McLeod DG, Benson RC Jr, Eisenberger MA, Crawford ED, Blumenstein BA, Spicer D, Spaulding JT. McLeod DG, et al. Cancer. 1993 Dec 15;72(12 Suppl):3870-3. doi: 10.1002/1097-0142(19931215)72:12+<3870::aid-cncr2820721721>3.0.co;2-e. Cancer. 1993. PMID: 8252506 Clinical Trial.
A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Casodex Combination Study Group.
Schellhammer P, Sharifi R, Block N, Soloway M, Venner P, Patterson AL, Sarosdy M, Vogelzang N, Jones J, Kolvenbag G. Schellhammer P, et al. Urology. 1995 May;45(5):745-52. doi: 10.1016/s0090-4295(99)80077-6. Urology. 1995. PMID: 7538237 Clinical Trial.
Chemohormonal therapy as primary treatment for metastatic prostate cancer: a randomized study of estramustine phosphate plus luteinizing hormone-releasing hormone agonist versus flutamide plus luteinizing hormone-releasing hormone agonist.
Noguchi M, Noda S, Yoshida M, Ueda S, Shiraishi T, Itoh K; Kurume-Kumamoto Estracyt Study Group. Noguchi M, et al. Int J Urol. 2004 Feb;11(2):103-9. doi: 10.1111/j.1442-2042.2004.t01-1-00748.x. Int J Urol. 2004. PMID: 14706014 Free article. Clinical Trial.
Leuprolide with and without flutamide in advanced prostate cancer.
Crawford ED, Blumenstein BA, Goodman PJ, Davis MA, Eisenberger MA, McLeod DG, Spaulding JT, Benson R, Dorr FA. Crawford ED, et al. Cancer. 1990 Sep 1;66(5 Suppl):1039-44. doi: 10.1002/cncr.1990.66.s5.1039. Cancer. 1990. PMID: 2118417 Clinical Trial.
Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.
Eisenberger MA, Blumenstein BA, Crawford ED, Miller G, McLeod DG, Loehrer PJ, Wilding G, Sears K, Culkin DJ, Thompson IM Jr, Bueschen AJ, Lowe BA. Eisenberger MA, et al. N Engl J Med. 1998 Oct 8;339(15):1036-42. doi: 10.1056/NEJM199810083391504. N Engl J Med. 1998. PMID: 9761805 Free article. Clinical Trial.
64 results